Our in-vivo approach intentionally employed a reductionist human OSCC xenograft configuration with adoptive human T cells and neutrophils to isolate the mechanistic sequence whereby tumor-intrinsic GINS2 promotes TAN recruitment, induces PD-L1 on TANs, and suppresses CD8+ T-cell function. The gene discussed is CD8A; the disease is neoplasm.